8:15 AM Program Overview
Chair: Ira M. Jacobson, MD
8:30 AM Interactive Plenary: Simplifying HCV Assessment and Treatment
Faculty: Jordan J. Feld, MD, MPH
9:00 AM Interactive Roundtable: Treating to Eliminate HCV: Case Discussion
Moderator: Nancy Reau, MD, FAASLD, AGAF
10:00 AM Question and Answer Session
10:30 AM Interactive Plenary: Treating Hepatitis B Now and in the Future
Faculty: Paul Y. Kwo, MD
11:00 AM Interactive Roundtable: Current Controversies and Challenging Cases in HBV Management
Moderator: Marion G. Peters, MD, FRACP
12:00 PM Question and Answer Session
12:30 PM Adjournment
Date / Time
Ira M. Jacobson, MD
Director of Hepatology
Department of Medicine
NYU School of Medicine
New York, New York
Jordan J. Feld, MD, MPH
Associate Professor of Medicine
University of Toronto
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California
Marion G. Peters, MD, FRACP
Chief of Hepatology Research
Professor of Medicine, Gastroenterology
University of California, San Francisco
San Francisco, California
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
The primary purpose of this program is to arm clinicians with tools to address the most important and most current challenges in viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic. The program will consist of 2 live half-day highly interactive workshops dedicated to viral hepatitis.
The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in HIV and viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.
This program is intended for HIV specialists, infectious diseases clinicians, hepatologists, gastroenterologists, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with HIV infection and/or viral hepatitis.
- Integrate the results of clinical studies of approved viral hepatitis treatments into optimized patient management strategies
- Apply key guidelines and study data to ensure appropriate, individualized management for diverse patient populations with viral hepatitis infection, based on individual patient factors
- Implement practical strategies to optimize outcomes in individuals with viral hepatitis
Physician Continuing Medical Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
4.2 contact hours may be earned for successful completion of this activity.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 4.2 contact hours.
Pharmacist Continuing Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program has been assigned ACPE Universal Activity #0797-9999-19-037-L01-P. This program is designated for up to 4.25 contact hours (0.425 CEUs) of continuing pharmacy education credit.
Type of Activity: Application
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.